EurekAlert!

Protein-based materials enter a new era with molecular design and AI-driven innovation

The review details how fibrous proteins such as collagen, keratin, and silk, along with adhesive proteins and elastin, can be tailored through chemical modifications and de novo molecular design to ...
Morningstar

Galux Achieves Breakthrough by Delivering High-Affinity De Novo Antibodies from Only 50 AI Designs, Marking a New Era in Precision Protein Design

Achieving over 30% success rate with just 50 designs, this milestone demonstrates a clear shift from serendipitous antibody discovery to precision design Galux, a South Korean biotech pioneering ...
BioTechniques

An AI update: deep learning-based molecular de novo design in drug discovery

Ola Engkvist is the Executive Director and Head of Molecular AI in Discovery Sciences within R&D at AstraZeneca (headquartered in Cambridge, UK). His team harnesses advanced computational technologies ...
EurekAlert!

Artificial intelligence revolutionizes anti-infective drug discovery: From target identification to lead optimization

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...